Latest Regulatory News

KALiNA Power has strengthened its financial position by selling a 180 MW load allocation for C$18 million, while advancing its Alberta gas-fired power projects amid evolving regulatory frameworks.

NT Minerals faces ASX trading suspension but pushes forward with exploration plans at Twin Peaks and Finniss River projects, while considering capital restructuring.

MinRex Resources has obtained a crucial ASX waiver allowing it to issue shares to Electrum Discovery shareholders without needing further shareholder approval, smoothing the path for its planned acquisition.

Platformo Ltd’s Biztrak software arm returned to positive cash flow and profitability in Q4 2025, driven by strategic cost control and digital expansion despite regulatory headwinds in Malaysia.

Immutep Limited has entered a strategic collaboration with Dr. Reddy’s, receiving a A$30 million upfront payment and potential milestones up to A$528 million, while reporting promising clinical progress across multiple cancer immunotherapy trials.

Bioxyne Limited has delivered a record-breaking second quarter in FY2026, posting $17.2 million in revenue and expanding its footprint into key international markets. The company’s growth is underpinned by new contracts, innovative psychedelics products, and strategic government funding.

Carnavale Resources has marked key progress at its Kookynie Gold Project, signing a pivotal Heritage and Mining Agreement and launching a Bankable Feasibility Study aimed at production by mid-2026.

Cooper Metals Limited is gearing up for significant drilling programs across its Queensland and Western Australia projects, supported by a robust cash position and favourable copper-gold market dynamics.

Far East Gold’s December quarter report highlights significant high-grade gold discoveries at its Idenburg Project and a key regulatory approval that paves the way for accelerated development.

Janus Electric has inked a strategic partnership with a Canadian consortium to deploy swappable battery electric trucks powered by innovative negative-carbon energy, aiming to revolutionise long-haul freight electrification.

Mesoblast Limited reported a 60% jump in Ryoncil sales to US$35 million for the December quarter, alongside securing a US$125 million credit facility that enhances its financial flexibility and supports ongoing clinical development.

Syntara Limited has made significant strides in its clinical pipeline, launching new trials and receiving key regulatory designations, positioning 2026 as a pivotal year for the company.